If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2007 DPhil (Physiology and Genomics), University of Oxford
  • 2001 M.S., Department of Pharmacology, National Cheng Kung University
  • 1999 B.S., School of Pharmacy, Taipei Medical University

Experience

  • 2018.05- Professor, Master Program in Applied Molecular Epidemiology, Taipei Medical University
  • 2018.01- Deputy Superintendent, College of Pharmacy, Taipei Medical University
  • 2015.08- Professor, Department of Clinical Pharmacy, Taipei Medical University
  • 2012.08-2015.07 Associate Professor, School of Pharmacy, Taipei Medical University
  • 2015.08- Associate Professor, Ph.D Program for Translational Medicine, Taipei Medical University
  • 2013.08- Associate Professor, Ph.D Program for Clinical Drug Discovery from Botanical Herbs, Taipei Medical University
  • 2013.08-2019.07 Director, Ph.D Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
  • 2013.08- Associate Professor, Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
  • 2012.10-2013.07 Director, Ph.D Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
  • 2012.08- Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
  • 2016.04-2017.04 Secretary General, The Pharmaceutical Society of Taiwan
  • 2009.02-2012.07 Assistant Professor, Kaohsiung Medical University
  • 2002.09-2003.10 Deputy Administrator, Food and Drug Administration of Taiwan

Research Interests

  • Genetic characterization of calcium channel related genes to establish personalized therapy
  • Molecular identification for human genetic variants and drug responses

Awards

  • 2019 Research Dissertation Award - Excellence Award, Taipei Medical University

Fingerprint Dive into the research topics where Wei-Chiao Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

CLEC5A: A Promiscuous Pattern Recognition Receptor to Microbes and Beyond

Sung, P. S., Chang, W. C. & Hsieh, S. L., Jan 1 2020, Advances in Experimental Medicine and Biology. Springer India, p. 57-73 17 p. (Advances in Experimental Medicine and Biology; vol. 1204).

Research output: Chapter in Book/Report/Conference proceedingChapter

  • 1 Citation (Scopus)

    HSPB1 rs2070804 polymorphism is associated with the depth of primary tumor

    Hung, C. S., Huang, C. Y., Hsu, Y. W., Makondi, P. T., Chang, W. C., Chang, Y. J., Wang, J. Y. & Wei, P. L., Jan 1 2020, In : Journal of Cellular Biochemistry. 121, 1, p. 63-69 7 p.

    Research output: Contribution to journalArticle

  • Association of endothelin genetic variants and hospitalized infection complications in end-stage renal disease (ESRD) patients

    Kao, C. C., Cheng, S. Y., Wang, Y. J., Chien, S. C., Hsu, Y. W., Wu, M. Y., Lu, H. F., Nam, S., Sun, T., Wu, M. S. & Chang, W. C., Jun 5 2019, In : BMC Nephrology. 20, 1, p. 203 203.

    Research output: Contribution to journalArticle

    Open Access
  • Cancers in Taiwan: Practical insight from epidemiology, treatments, biomarkers, and cost

    Kuo, C. N., Liao, Y. M., Kuo, L. N., Tsai, H. J., Chang, W. C. & Yen, Y., Jan 1 2019, (Accepted/In press) In : Journal of the Formosan Medical Association.

    Research output: Contribution to journalReview article

    Open Access
  • 3 Citations (Scopus)